Recurrent, metastatic Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

Drug	Drug Name	Drug Description
DB00642	Pemetrexed	A folate analog used to treat mesothelioma and non-small cell lung cancer.

Drug	Drug Name	Target	Type
DB00642	Pemetrexed	Thymidylate synthase	target
DB00642	Pemetrexed	Dihydrofolate reductase	target
DB00642	Pemetrexed	Trifunctional purine biosynthetic protein adenosine-3	target
DB00642	Pemetrexed	Deoxycytidine kinase	enzyme
DB00642	Pemetrexed	Bifunctional purine biosynthesis protein PURH	target
DB00642	Pemetrexed	Equilibrative nucleoside transporter 1	enzyme
DB00642	Pemetrexed	Solute carrier family 22 member 8	transporter
DB00642	Pemetrexed	Folate transporter 1	transporter
DB00642	Pemetrexed	Proton-coupled folate transporter	transporter
DB00642	Pemetrexed	ATP-binding cassette sub-family G member 2	transporter
DB00642	Pemetrexed	Multidrug resistance-associated protein 5	transporter
DB00642	Pemetrexed	Solute carrier family 22 member 6	transporter
DB00642	Pemetrexed	Serum albumin	carrier
DB00642	Pemetrexed	Solute carrier family 22 member 11	transporter

Drug	Drug Name	Phase	Status	Count